Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional study.

Thacker EL, Muntner P, Zhao H, Safford MM, Curtis JR, Delzell E, Bittner V, Brown TM, Levitan EB.

BMC Health Serv Res. 2014 Apr 29;14:195. doi: 10.1186/1472-6963-14-195.

2.

Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims.

Kumamaru H, Judd SE, Curtis JR, Ramachandran R, Hardy NC, Rhodes JD, Safford MM, Kissela BM, Howard G, Jalbert JJ, Brott TG, Setoguchi S.

Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):611-9. doi: 10.1161/CIRCOUTCOMES.113.000743. Epub 2014 Jun 24.

3.

Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Muntner P, GutiƩrrez OM, Zhao H, Fox CS, Wright NC, Curtis JR, McClellan W, Wang H, Kilgore M, Warnock DG, Bowling CB.

Am J Kidney Dis. 2015 Feb;65(2):249-58. doi: 10.1053/j.ajkd.2014.07.012. Epub 2014 Sep 19.

4.

Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.

Muntner P, Colantonio LD, Cushman M, Goff DC Jr, Howard G, Howard VJ, Kissela B, Levitan EB, Lloyd-Jones DM, Safford MM.

JAMA. 2014 Apr 9;311(14):1406-15. doi: 10.1001/jama.2014.2630.

5.

LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.

Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C.

J Manag Care Pharm. 2007 Oct;13(8):652-63.

6.

Optimal use of available claims to identify a Medicare population free of coronary heart disease.

Kent ST, Safford MM, Zhao H, Levitan EB, Curtis JR, Kilpatrick RD, Kilgore ML, Muntner P.

Am J Epidemiol. 2015 Nov 1;182(9):808-19. doi: 10.1093/aje/kwv116. Epub 2015 Oct 5.

7.

An algorithm for the use of Medicare claims data to identify women with incident breast cancer.

Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL.

Health Serv Res. 2004 Dec;39(6 Pt 1):1733-49.

8.

Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.

Foster MC, Rawlings AM, Marrett E, Neff D, Grams ME, Kasiske BL, Willis K, Inker LA, Coresh J, Selvin E.

Am J Kidney Dis. 2014 May;63(5):753-60. doi: 10.1053/j.ajkd.2013.11.014. Epub 2013 Dec 25.

9.

Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis).

Blankstein R, Budoff MJ, Shaw LJ, Goff DC Jr, Polak JF, Lima J, Blumenthal RS, Nasir K.

J Am Coll Cardiol. 2011 Jul 19;58(4):364-74. doi: 10.1016/j.jacc.2011.01.055.

10.

Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.

Rosenson RS, Kent ST, Brown TM, Farkouh ME, Levitan EB, Yun H, Sharma P, Safford MM, Kilgore M, Muntner P, Bittner V.

J Am Coll Cardiol. 2015 Jan 27;65(3):270-7. doi: 10.1016/j.jacc.2014.09.088.

11.
12.

Prevalence of cardiovascular comorbidities and utilization of evidence-based treatment strategies among statin users in a Medicare and commercial health plan.

Aronow HD, Dutro MP, Kuznik A, Cwengros J.

Curr Med Res Opin. 2009 Jan;25(1):205-13. doi: 10.1185/03007990802611828 .

PMID:
19210153
14.

Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography.

Fenton JJ, Onega T, Zhu W, Balch S, Smith-Bindman R, Henderson L, Sprague BL, Kerlikowske K, Hubbard RA.

Med Care. 2016 Mar;54(3):e15-22. doi: 10.1097/MLR.0b013e3182a303d7.

15.

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

JAMA. 2002 Dec 18;288(23):2998-3007.

PMID:
12479764
16.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
18.

Identification of individuals with CKD from Medicare claims data: a validation study.

Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH.

Am J Kidney Dis. 2005 Aug;46(2):225-32.

PMID:
16112040
19.

Use of Medicare claims to rank hospitals by surgical site infection risk following coronary artery bypass graft surgery.

Huang SS, Placzek H, Livingston J, Ma A, Onufrak F, Lankiewicz J, Kleinman K, Bratzler D, Olsen MA, Lyles R, Khan Y, Wright P, Yokoe DS, Fraser VJ, Weinstein RA, Stevenson K, Hooper D, Vostok J, Datta R, Nsa W, Platt R.

Infect Control Hosp Epidemiol. 2011 Aug;32(8):775-83. doi: 10.1086/660874.

PMID:
21768761
20.

Outcomes after coronary artery calcium and other cardiovascular biomarker testing among asymptomatic medicare beneficiaries.

Shreibati JB, Baker LC, McConnell MV, Hlatky MA.

Circ Cardiovasc Imaging. 2014 Jul;7(4):655-62. doi: 10.1161/CIRCIMAGING.113.001869. Epub 2014 Apr 28.

Supplemental Content

Support Center